Search research articles
Contact Us
Filters
Showing results (51-60 of 69) with videos related to
Page
of 7
Sort By:
Diabetologia
|
February 3, 2016
Autophagy is a major regulator of beta cell insulin homeostasis
Yael Riahi, Jakob D Wikstrom, Etty Bachar-Wikstrom, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
June 20, 2022
Novel roles of mTORC2 in regulation of insulin secretion by actin filament remodeling
Manuel Blandino-Rosano, Joshua O Scheys, Joao Pedro Werneck-de-Castro, et al.
Elife
|
November 10, 2018
Inhibition of mTORC1 by ER stress impairs neonatal β-cell expansion and predisposes to diabetes in the <i>Akita</i> mouse
Yael Riahi, Tal Israeli, Roni Yeroslaviz, et al.
Npj Metabolic Health and Disease
|
June 17, 2026
CD59 drives diet-induced obesity and glucose intolerance, insulin resistance, and metabolic dysfunction-associated steatotic liver disease
Marian Zeibak, Netanel Karbian, Yael Riahi, et al.
Molecular Metabolism
|
June 23, 2025
Metabolic consequences of altered kidney glucose reabsorption under normoglycemic conditions
Majdoleen Ahmad, Anna Permyakova, Saja Baraghithy, et al.
The Journal of Clinical Investigation
|
January 2, 2026
JNK3 regulates β cell responses to incretins in human islets and mouse models
Ruy A Louzada, Marel Gonzalez Medina, Valentina Pita-Grisanti, et al.
Diabetologia
|
July 22, 2023
Hyperglucagonaemia in diabetes: altered amino acid metabolism triggers mTORC1 activation, which drives glucagon production
Yael Riahi, Aviram Kogot-Levin, Liat Kadosh, et al.
Diabetes Care
|
May 26, 2016
Predisposing Factors for Any and Major Hypoglycemia With Saxagliptin Versus Placebo and Overall: Analysis From the SAVOR-TIMI 53 Trial
Avivit Cahn, Itamar Raz, Ofri Mosenzon, et al.
Diabetes Care
|
November 1, 2016
Effect of Saxagliptin on Renal Outcomes in the SAVOR-TIMI 53 Trial
Ofri Mosenzon, Gil Leibowitz, Deepak L Bhatt, et al.
Journal of the American Society of Nephrology : JASN
|
October 15, 2017
Modulation of Renal GLUT2 by the Cannabinoid-1 Receptor: Implications for the Treatment of Diabetic Nephropathy
Liad Hinden, Shiran Udi, Adi Drori, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 69) with videos related to
Sort By:
Page
of 7
Diabetologia
|
February 3, 2016
Autophagy is a major regulator of beta cell insulin homeostasis
Yael Riahi, Jakob D Wikstrom, Etty Bachar-Wikstrom, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
June 20, 2022
Novel roles of mTORC2 in regulation of insulin secretion by actin filament remodeling
Manuel Blandino-Rosano, Joshua O Scheys, Joao Pedro Werneck-de-Castro, et al.
Elife
|
November 10, 2018
Inhibition of mTORC1 by ER stress impairs neonatal β-cell expansion and predisposes to diabetes in the <i>Akita</i> mouse
Yael Riahi, Tal Israeli, Roni Yeroslaviz, et al.
Npj Metabolic Health and Disease
|
June 17, 2026
CD59 drives diet-induced obesity and glucose intolerance, insulin resistance, and metabolic dysfunction-associated steatotic liver disease
Marian Zeibak, Netanel Karbian, Yael Riahi, et al.
Molecular Metabolism
|
June 23, 2025
Metabolic consequences of altered kidney glucose reabsorption under normoglycemic conditions
Majdoleen Ahmad, Anna Permyakova, Saja Baraghithy, et al.
The Journal of Clinical Investigation
|
January 2, 2026
JNK3 regulates β cell responses to incretins in human islets and mouse models
Ruy A Louzada, Marel Gonzalez Medina, Valentina Pita-Grisanti, et al.
Diabetologia
|
July 22, 2023
Hyperglucagonaemia in diabetes: altered amino acid metabolism triggers mTORC1 activation, which drives glucagon production
Yael Riahi, Aviram Kogot-Levin, Liat Kadosh, et al.
Diabetes Care
|
May 26, 2016
Predisposing Factors for Any and Major Hypoglycemia With Saxagliptin Versus Placebo and Overall: Analysis From the SAVOR-TIMI 53 Trial
Avivit Cahn, Itamar Raz, Ofri Mosenzon, et al.
Diabetes Care
|
November 1, 2016
Effect of Saxagliptin on Renal Outcomes in the SAVOR-TIMI 53 Trial
Ofri Mosenzon, Gil Leibowitz, Deepak L Bhatt, et al.
Journal of the American Society of Nephrology : JASN
|
October 15, 2017
Modulation of Renal GLUT2 by the Cannabinoid-1 Receptor: Implications for the Treatment of Diabetic Nephropathy
Liad Hinden, Shiran Udi, Adi Drori, et al.
Page
of 7